Endogena is a clinical-stage biotechnology company that discovers and develops first-in-class endogenous regenerative medicines to repair diseased tissues. Our unique approach has the potential for a paradigm shift in how degenerative conditions due to aging and genetic disorders are treated.
Products, services, technology
Endogena Therapeutics’ novel drug discovery approach is based on the concept of leveraging artificial intelligence to identify small molecules that can selectively re-activate dormant endogenous stem- or progenitor cells, allowing them to initiate a natural local tissue repair process.
Partnering, scientific collaborations, funding
We develop novel therapies for patients with unmet medical needs.
We are a diverse team of highly experienced individuals. We love to discover and develop. Science is at the heart of everything we do and helps us to pursue our purpose. During the last 6 years we have achieved incredible milestones in a short timespan and with limited resources.
What are the core strengths of your current team and what skills are you looking forward to integrate in the future?
We all have drug development expertise. As our programs develop, we would be looking into team members with a commercial mindset and sales & marketing skills.
Networking opportunities, learning & development, partnerships, industry news
Institutional Investors, Angels, Scientific collaborators, pharmaceutical companies interested in partnering